Skip to main content
Erschienen in: Virchows Archiv 2/2006

01.08.2006 | Original Article

Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes

verfasst von: Barbara Guertl, Ivo Leuschner, Dieter Harms, Gerald Hoefler

Erschienen in: Virchows Archiv | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Nephroblastomas are embryonal tumors exhibiting a wide variety of different morphological features and genetic changes. Some of the genetic aberrations were associated with a certain histological subtype. It is generally assumed that nephroblastomas develop as subclonal proliferations from nephrogenic rests. However, so far, a very limited amount of tumors from only part of the morphological spectrum of nephroblastomas was investigated. We therefore investigated the clonality of 45 tumors of all different histological subtypes. The number of each subtype was in accordance with the percentage of occurrence of the respective subtype. We analyzed a highly polymorphic locus of the human androgen receptor gene for nonrandom X-inactivation of genomic DNA using a methylation-sensitive restriction enzyme. Data were obtained for 39 tumors. Eighteen of the tumors included were noninformative in the genetic locus examined, the remaining 21 tumors were monoclonal regardless of the histological subtype. Our findings therefore support the hypothesis that Wilms’ tumors are monoclonal proliferations despite their large variety of morphological features.
Literatur
1.
Zurück zum Zitat Astuti D, DaSilva NF, Dallol A, Gentle D, Martinsson T, Kogner P, Grundy R, Kishida T, Yao M, Latif F, Maher ER (2004) SLIT2 promoter methylation analysis in neuroblastoma, Wilms’ tumour and renal cell carcinoma. Br J Cancer 90:515–521CrossRefPubMed Astuti D, DaSilva NF, Dallol A, Gentle D, Martinsson T, Kogner P, Grundy R, Kishida T, Yao M, Latif F, Maher ER (2004) SLIT2 promoter methylation analysis in neuroblastoma, Wilms’ tumour and renal cell carcinoma. Br J Cancer 90:515–521CrossRefPubMed
2.
Zurück zum Zitat Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J (1994) Anaplastic Wilms’ tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7:91–97CrossRefPubMed Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J (1994) Anaplastic Wilms’ tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7:91–97CrossRefPubMed
3.
Zurück zum Zitat Bardeesy N, Beckwith JB, Pelletier J (1995) Clonal expansion and attenuated apoptosis in Wilms’ tumor are associated with p53 gene mutations. Cancer Res 55:215–219PubMed Bardeesy N, Beckwith JB, Pelletier J (1995) Clonal expansion and attenuated apoptosis in Wilms’ tumor are associated with p53 gene mutations. Cancer Res 55:215–219PubMed
4.
Zurück zum Zitat Beckwith JB (1993) Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol 21:178–181CrossRef Beckwith JB (1993) Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol 21:178–181CrossRef
5.
Zurück zum Zitat Beckwith JB, Kiviat NB, Bonadio JF (1990) Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms’ tumor. Pediatr Pathol 10:1–36PubMedCrossRef Beckwith JB, Kiviat NB, Bonadio JF (1990) Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms’ tumor. Pediatr Pathol 10:1–36PubMedCrossRef
6.
Zurück zum Zitat Boily G, Saikali Z, Sinnett D (2004) Methylation analysis of the glypican 3 gene in embryonal tumours. Br J Cancer 90:1606–1611CrossRefPubMed Boily G, Saikali Z, Sinnett D (2004) Methylation analysis of the glypican 3 gene in embryonal tumours. Br J Cancer 90:1606–1611CrossRefPubMed
7.
Zurück zum Zitat Breslow NE, Olshan A, Beckwith JB, Green DM (1993) Epidemiology of Wilms tumor. Med Pediatr Oncol 21:178–181CrossRef Breslow NE, Olshan A, Beckwith JB, Green DM (1993) Epidemiology of Wilms tumor. Med Pediatr Oncol 21:178–181CrossRef
8.
Zurück zum Zitat Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P (1996) Familial Wilms’ tumor: a descriptive study. Med Pediatr Oncol 27:398–403CrossRefPubMed Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P (1996) Familial Wilms’ tumor: a descriptive study. Med Pediatr Oncol 27:398–403CrossRefPubMed
9.
Zurück zum Zitat Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 60:509–520CrossRefPubMed Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 60:509–520CrossRefPubMed
10.
Zurück zum Zitat Charles AK, Brown KW, Berry PJ (1998) Microdissecting the genetic events in nephrogenic rests and Wilms tumor development. Am J Pathol 153:991–1000PubMed Charles AK, Brown KW, Berry PJ (1998) Microdissecting the genetic events in nephrogenic rests and Wilms tumor development. Am J Pathol 153:991–1000PubMed
11.
Zurück zum Zitat Faria P, Beckwith JB, Mishra K, Zuppan C, Weeks DA, Breslow N, Green DM (1996) Focal versus diffuse anaplasia in Wilms tumor—new definitions with prognostic significance: a report from the National Wilms Tumor Study Group. Am J Surg Pathol 20:909–920PubMedCrossRef Faria P, Beckwith JB, Mishra K, Zuppan C, Weeks DA, Breslow N, Green DM (1996) Focal versus diffuse anaplasia in Wilms tumor—new definitions with prognostic significance: a report from the National Wilms Tumor Study Group. Am J Surg Pathol 20:909–920PubMedCrossRef
12.
Zurück zum Zitat Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE (2004) Myogenesis in Wilms’ tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Pediatr Dev Pathol 7:125–137CrossRefPubMed Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE (2004) Myogenesis in Wilms’ tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Pediatr Dev Pathol 7:125–137CrossRefPubMed
13.
Zurück zum Zitat Gerald WL, Gramling TS, Sens DA, Garvin AJ (1992) Expression of the 11p13 Wilms’ tumor gene, WT1, correlates with histologic category of Wilms’ tumor. Am J Pathol 140:1031–1037PubMed Gerald WL, Gramling TS, Sens DA, Garvin AJ (1992) Expression of the 11p13 Wilms’ tumor gene, WT1, correlates with histologic category of Wilms’ tumor. Am J Pathol 140:1031–1037PubMed
14.
Zurück zum Zitat Grundy P, Coopes M (1996) An overview of the clinical and molecular genetics of Wilms’ tumor. Med Pediatr Oncol 27:394–397CrossRefPubMed Grundy P, Coopes M (1996) An overview of the clinical and molecular genetics of Wilms’ tumor. Med Pediatr Oncol 27:394–397CrossRefPubMed
15.
Zurück zum Zitat Guertl B, Ratschek M, Harms D, Jaenig U, Leuschner I, Poremba C, Hoefler G (2003) Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas. Hum Pathol 34:278–281CrossRefPubMed Guertl B, Ratschek M, Harms D, Jaenig U, Leuschner I, Poremba C, Hoefler G (2003) Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas. Hum Pathol 34:278–281CrossRefPubMed
16.
Zurück zum Zitat Karnik P, Chen P, Paris M, Yeger H, Williams BR (1998) Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions. Oncogene 7:237–240CrossRef Karnik P, Chen P, Paris M, Yeger H, Williams BR (1998) Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions. Oncogene 7:237–240CrossRef
17.
Zurück zum Zitat Kopp P, Jaggi R, Tobler A, Borisch B, Oestreicher M, Sabacan L, Jameson JL, Fey MF (1997) Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue. Mol Cell Probes 11:217–228CrossRefPubMed Kopp P, Jaggi R, Tobler A, Borisch B, Oestreicher M, Sabacan L, Jameson JL, Fey MF (1997) Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue. Mol Cell Probes 11:217–228CrossRefPubMed
18.
Zurück zum Zitat Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Houseman D, Jaenisch R (1993) WT-1 is required for early kidney development. Cell 74:679–691CrossRefPubMed Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Houseman D, Jaenisch R (1993) WT-1 is required for early kidney development. Cell 74:679–691CrossRefPubMed
19.
Zurück zum Zitat Li Cm, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D´Agati V, Licht JD, Tycko B (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms tumors. Am J Pathol 165:1943–1953PubMed Li Cm, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D´Agati V, Licht JD, Tycko B (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms tumors. Am J Pathol 165:1943–1953PubMed
20.
21.
Zurück zum Zitat Mierau GW, Beckwith JB, Weeks DA (1987) Ultrastructure and histogenesis of the renal tumors of childhood: an overview. Ultrastruct Pathol 11:313–333PubMedCrossRef Mierau GW, Beckwith JB, Weeks DA (1987) Ultrastructure and histogenesis of the renal tumors of childhood: an overview. Ultrastruct Pathol 11:313–333PubMedCrossRef
22.
Zurück zum Zitat Miwa H, Tomlinson GF, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF (1992) RNA expression of the WT1 gene in Wilms’ tumors in relation to histology. J Natl Cancer Inst 84:181–187PubMedCrossRef Miwa H, Tomlinson GF, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF (1992) RNA expression of the WT1 gene in Wilms’ tumors in relation to histology. J Natl Cancer Inst 84:181–187PubMedCrossRef
23.
Zurück zum Zitat Murphy WM, Beckwith JB, Farrow GM (1994) Tumors of the kidney, bladder, and related urinary structures. In: Atlas of tumor pathology, 3rd series, fascicle 11. Armed Forces Institute of Pathology, Washington, pp 12–54 Murphy WM, Beckwith JB, Farrow GM (1994) Tumors of the kidney, bladder, and related urinary structures. In: Atlas of tumor pathology, 3rd series, fascicle 11. Armed Forces Institute of Pathology, Washington, pp 12–54
24.
Zurück zum Zitat Ramburan A, Oladiran F, Smith C, Hadley GP, Govender D (2005) Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy. J Clin Pathol 58:44–50CrossRefPubMed Ramburan A, Oladiran F, Smith C, Hadley GP, Govender D (2005) Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy. J Clin Pathol 58:44–50CrossRefPubMed
25.
Zurück zum Zitat Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Roya-Pokora B (1997) Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972–3977CrossRefPubMed Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Roya-Pokora B (1997) Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972–3977CrossRefPubMed
26.
Zurück zum Zitat Wilimas JA, Dow LW, Douglass EC, Jenkins JJIII, Jacobson RJ, Moohr J, Fialkow PJ (1991) Evidence for clonal development of Wilms’ tumor. Am J Pediatr Hematol Oncol 13:26–28PubMedCrossRef Wilimas JA, Dow LW, Douglass EC, Jenkins JJIII, Jacobson RJ, Moohr J, Fialkow PJ (1991) Evidence for clonal development of Wilms’ tumor. Am J Pediatr Hematol Oncol 13:26–28PubMedCrossRef
Metadaten
Titel
Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes
verfasst von
Barbara Guertl
Ivo Leuschner
Dieter Harms
Gerald Hoefler
Publikationsdatum
01.08.2006
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 2/2006
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-006-0225-2

Weitere Artikel der Ausgabe 2/2006

Virchows Archiv 2/2006 Zur Ausgabe

Announcements

Announcements

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …